Organization
Vigonvita Life Sciences
18 clinical trials
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Deuremidevir Hydrobromide for Suspension in Hospitalized Infants Infected With Respiratory Syncytial Virus.Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Food Effects of a Single Oral VV119 Capsule in Healthy Chinese VolunteersStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Evaluate the Acute Effects of a Single Oral Dose of TPN171H on Semen Function in Healthy Male Subjects in ChinaStatus: Completed, Estimated PCD: 2022-12-16
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Two-cohort, Three-way Crossover Clinical Trial to Evaluate the Pharmacodynamic Effect of Different Doses of TPN171H Tablets in Mild to Moderate Male Erectile DysfunctionStatus: Completed, Estimated PCD: 2023-01-04
Clinical trial
a Parallel, Open, Single-dose Administration Phase I Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy SubjectsStatus: Completed, Estimated PCD: 2022-10-25
Clinical trial
Phase Ib Clinical Study on the Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in the Treatment of Pulmonary Arterial Hypertension (PAH) PatientsStatus: Completed, Estimated PCD: 2020-10-14
Clinical trial
A Multicenter, Single-blind, Randomized, Controlled Study to Evaluate the Efficacy and Safety of JT001 (VV116) Compared With Paxlovid for the Early Treatment of COVID-19 in Participants With Mild to Moderate COVID-19Status: Completed, Estimated PCD: 2022-05-13
Clinical trial
A Single-dose-oral, Ascending-Dose, Single-Center,Randomized, Double-Blind, Placebo-Parallel-controlled Study for the Evaluation of the Effect of TPN171H Tablets on the QT/QTc Intervals in Adult Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-07
Clinical trial
A Phase I Clinical Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetic Characteristics of Oral Deuremidevir Hydrobromide for Suspension in Chinese Healthy VolunteersStatus: Completed, Estimated PCD: 2023-09-04
Clinical trial
A Phase 1,Parallel Assignment,Fixed-Sequence Study to Assess the Effect of Itraconazole, Rifampicin on the Pharmacokinetics of TPN171H in Healthy SubjectsStatus: Completed, Estimated PCD: 2020-04-27
Clinical trial
A Study Evaluating Safety and Pharmacokinetics of a Single Oral TPN171H in Elderly SubjectsStatus: Completed, Estimated PCD: 2020-12-14
Clinical trial
A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Dose-Exploring Study to Evaluate the Efficacy and Safety of TPN171H in China Male Patients With Erectile DysfunctionStatus: Completed, Estimated PCD: 2021-07-26
Clinical trial
A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of TPN171H in Patients With Erectile DysfunctionStatus: Completed, Estimated PCD: 2023-02-14
Clinical trial
A Multicenter, Open Study to Evaluate the Long-term Safety and Efficacy of TPN171H in Patients With Erectile DysfunctionStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules in Chinese Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Multiple-dose, Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension in Chinese Healthy VolunteersStatus: Completed, Estimated PCD: 2024-05-06
Clinical trial
A Randomized, Double-blind, Placebo-Controlled, Single-Centre,Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Non-Randomized, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of LV232 Capsule Assessing Serotonin Transporter Occupancy in the Healthy Adult Brain Using 11C-DASB Positron Emission Tomography (PET)Status: Not yet recruiting, Estimated PCD: 2024-09-01